安儿宁颗粒治疗小儿急性支气管炎伴发热的疗效OA

Objective To explore the clinical effect of Anerning granule on acute bronchitis with fever in children.Methods A total of 78 children with acute bronchitis with fever treated in Ruijin People's Hospital from February 2022 to March 2023 were selected as the study objects and randomly divided into control group and observation group,with 39 cases in each group.The control group was treated with amoxicillin and clavulanate potassium for injection,and the observation group was treated with An'erning granule.Clinical symptom score,inflammatory index,immune function and lung function were compared between the two groups before and after treatment.Results After treatment,the scores of fever,cough,sputum and pulmonary rales in the two groups were decreased,and the observation group was lower than the control group,the difference was statistically significant(P＜0.05).After treatment,the white blood cell count and C-reactive protein level of the two groups were decreased,and the observation group was lower than the control group,the difference was statistically significant(P＜0.05).After treatment,the levels of immunoglobulin A,immunoglobulin G and immunoglobulin M in the two groups were increased,and the observation group was higher than the control group,the difference was statistically significant(P＜0.05).After treatment,tidal volume,expiratory and inspiratory time increased,and respiratory rate decreased,and the change range of observation group was significantly greater than that of control group,the difference was statistically significant(P＜0.05).Conclusion Anerning granules can inhibit the inflammatory response of acute bronchitis with fever in children,improve the related symptoms and immune function,and help the lung function of children to return to normal as soon as possible.